Bakakos A, Sotiropoulou Z, Vontetsianos A, Zaneli S, Papaioannou A, Bakakos P
J Asthma Allergy. 2023; 16:1025-1040.
PMID: 37791040
PMC: 10543746.
DOI: 10.2147/JAA.S277455.
Boboltz A, Kumar S, Duncan G
Adv Drug Deliv Rev. 2023; 198:114858.
PMID: 37178928
PMC: 10330872.
DOI: 10.1016/j.addr.2023.114858.
Montamat G, Leonard C, Poli A, Klimek L, Ollert M
Front Immunol. 2021; 12:590054.
PMID: 33708195
PMC: 7940844.
DOI: 10.3389/fimmu.2021.590054.
Dorofeeva Y, Shilovskiy I, Tulaeva I, Focke-Tejkl M, Flicker S, Kudlay D
Allergy. 2020; 76(1):131-149.
PMID: 32249442
PMC: 7818275.
DOI: 10.1111/all.14300.
Alberca Custodio R, Mirotti L, Gomes E, Nunes F, S Vieira R, Graca L
Cells. 2019; 8(10).
PMID: 31569343
PMC: 6829343.
DOI: 10.3390/cells8101165.
TLRs in pulmonary diseases.
Arora S, Ahmad S, Irshad R, Goyal Y, Rafat S, Siddiqui N
Life Sci. 2019; 233:116671.
PMID: 31336122
PMC: 7094289.
DOI: 10.1016/j.lfs.2019.116671.
Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases.
Mehta M, Deeksha , Tewari D, Gupta G, Awasthi R, Singh H
Chem Biol Interact. 2019; 308:206-215.
PMID: 31136735
PMC: 7094617.
DOI: 10.1016/j.cbi.2019.05.028.
Lung Interstitial Macrophages: Past, Present, and Future.
Schyns J, Bureau F, Marichal T
J Immunol Res. 2018; 2018:5160794.
PMID: 29854841
PMC: 5952507.
DOI: 10.1155/2018/5160794.
Nanoparticle-based CpG-oligonucleotide therapy for treating allergic asthma.
Givens B, Geary S, Salem A
Immunotherapy. 2018; 10(7):595-604.
PMID: 29569508
PMC: 6367711.
DOI: 10.2217/imt-2017-0142.
Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae.
Kataoka K, Fukuyama Y, Briles D, Miyake T, Fujihashi K
Microbiol Immunol. 2017; 61(6):195-205.
PMID: 28463465
PMC: 5529118.
DOI: 10.1111/1348-0421.12487.
CpG-ODN Shapes Alum Adjuvant Activity Signaling MyD88 and IL-10.
Mirotti L, Custodio R, Gomes E, Rammauro F, de Araujo E, Calich V
Front Immunol. 2017; 8:47.
PMID: 28220116
PMC: 5289984.
DOI: 10.3389/fimmu.2017.00047.
Holding the Inflammatory System in Check: TLRs and Their Targeted Therapy in Asthma.
Dong Z, Xiong L, Zhang W, Gibson P, Wang T, Lu Y
Mediators Inflamm. 2016; 2016:2180417.
PMID: 27274620
PMC: 4870363.
DOI: 10.1155/2016/2180417.
Advances in the treatment of virus-induced asthma.
Tay H, Wark P, Bartlett N
Expert Rev Respir Med. 2016; 10(6):629-41.
PMID: 27088397
PMC: 7103718.
DOI: 10.1080/17476348.2016.1180249.
CpG Oligodeoxynucleotide Inhibits Cockroach-Induced Asthma via Induction of IFN-γ⁺ Th1 Cells or Foxp3⁺ Regulatory T Cells in the Lung.
Kim D, Ho Sohn J, Park H, Lee J, Park J, Choi J
Allergy Asthma Immunol Res. 2016; 8(3):264-75.
PMID: 26922937
PMC: 4773215.
DOI: 10.4168/aair.2016.8.3.264.
Nanoparticle conjugation enhances the immunomodulatory effects of intranasally delivered CpG in house dust mite-allergic mice.
Ballester M, Jeanbart L, de Titta A, Nembrini C, Marsland B, Hubbell J
Sci Rep. 2015; 5:14274.
PMID: 26387548
PMC: 4585708.
DOI: 10.1038/srep14274.
Hydroxypropyl-β-cyclodextrin spikes local inflammation that induces Th2 cell and T follicular helper cell responses to the coadministered antigen.
Onishi M, Ozasa K, Kobiyama K, Ohata K, Kitano M, Taniguchi K
J Immunol. 2015; 194(6):2673-82.
PMID: 25681338
PMC: 4470223.
DOI: 10.4049/jimmunol.1402027.
The dichotomy of pathogens and allergens in vaccination approaches.
Baird F, Lopata A
Front Microbiol. 2014; 5:365.
PMID: 25076945
PMC: 4100532.
DOI: 10.3389/fmicb.2014.00365.
A limited CpG-containing oligodeoxynucleotide therapy regimen induces sustained suppression of allergic airway inflammation in mice.
Campbell J, Kell S, Kozy H, Lum J, Sweetwood R, Chu M
Thorax. 2014; 69(6):565-573.
PMID: 24464743
PMC: 4558941.
DOI: 10.1136/thoraxjnl-2013-204605.
Antibody to mCLCA3 suppresses symptoms in a mouse model of asthma.
Song L, Liu D, Wu C, Wu S, Yang J, Ren F
PLoS One. 2013; 8(12):e82367.
PMID: 24349268
PMC: 3857274.
DOI: 10.1371/journal.pone.0082367.
Toll-like receptor-2/6 and Toll-like receptor-9 agonists suppress viral replication but not airway hyperreactivity in guinea pigs.
Drake M, Evans S, Dickey B, Fryer A, Jacoby D
Am J Respir Cell Mol Biol. 2013; 48(6):790-6.
PMID: 23449736
PMC: 3727870.
DOI: 10.1165/rcmb.2012-0498OC.